HomeNewsBusinessReal EstateReal estate developers in Maharashtra undertake precautionary measures at sites as COVID-19 cases rise

Real estate developers in Maharashtra undertake precautionary measures at sites as COVID-19 cases rise

Urge the government to prioritise vaccination for workers above 18 years

April 06, 2021 / 17:30 IST
Story continues below Advertisement

With COVID-19 cases rising in Maharashtra, several real estate developers are undertaking precautionary measures as mandated by the state government to ensure the safety of workers at construction sites and have urged the government to prioritise vaccination for workers above 18 years.

On April 4, the state government had announced several restrictions for containment of COVID-19 for the period up to April 30, 2021. Construction activity is to be allowed only for sites where labourers’ are living on site. Movement to and from the site must be avoided, except for the purposed of material movements.

Story continues below Advertisement

The new guidelines have said that everyone engaged in the activity needs to get vaccinated at the earliest, as per criteria of GOI and until that is done they would have to carry a negative RTPCR test result certificate, which will be valid for 15 days. This rule will come into effect from April 10, 2021, the guidelines have said.

They have said that any defaults will lead to a fine of Rs 10,000 for the developer of the construction site and repeated defaults may lead to closure of the site till existence of notification of COVID-19 epidemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show